Genpact LTD G
Genpact is an agentic and advanced technology solutions company recognized for its deep industry knowledge, process intelligence and last mile expertise. With decades of client trust and a strong partner ecosystem, we provide innovative solutions that transform how businesses run. Powered by a team with an active learning mindset and client centricity at its core, we deliver lasting value for the world's leading enterprises.
We have over 146,500 employees and serve clients from more than 35 countries around the world. Our 2025 total net revenues were $5.1 billion.
Genpact was established more than 25 years ago as the global capability center for the General Electric Company ("GE"). Our mandate was to perfect a set of shared business processes using Lean Six Sigma and other rigorous methodologies. The work was highly detailed and operationally complex, establishing Genpact as one of the world's leading business process experts. This operational discipline, combined with our end-to-end process view, granular data benchmarking capabilities, and operator-led approach has shaped our culture and core competencies in process design, data management, and industry domain knowledge. We believe this foundational process intelligence positions us to deliver differentiated AI and agentic solutions that address the operational complexities and "last mile" execution challenges our clients are facing.
Valuation FY2025 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by geography
- India
- Asia, other than India
- North and Latin America
- Europe
| Region | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| India | $2.98B | $2.76B | $2.32B |
| Asia, other than India | $788.1M | $700.3M | $643.1M |
| North and Latin America | $730.4M | $683.4M | $979.9M |
| Europe | $578.4M | $621.9M | $533.0M |
As the company reported it, from the “Segment reporting - Schedule of Net Revenues From Geographic Areas (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.08B | $4.77B | $4.48B | $4.37B | $4.02B | $3.71B | $3.52B | $3.00B | $2.74B | $2.57B |
| Cost of revenue | $3.25B | $3.08B | $2.91B | $2.83B | $2.59B | $2.42B | $2.29B | $1.92B | $1.68B | $1.55B |
| Gross profit | $1.83B | $1.69B | $1.57B | $1.54B | $1.43B | $1.29B | $1.23B | $1.08B | $1.06B | $1.02B |
| SG&A | $1.05B | $967.1M | $913.1M | $938.4M | $865.7M | $789.8M | $794.9M | $693.9M | $689.5M | $653.0M |
| Operating income | $750.2M | $702.1M | $630.9M | $502.2M | $509.0M | $438.7M | $429.4M | $348.2M | $331.3M | $341.2M |
| Interest expense | — | $79.5M | $66.3M | $58.1M | — | — | — | — | — | — |
| Pre-tax income | $730.1M | $676.8M | $602.2M | $465.2M | $483.1M | $400.5M | $399.4M | $362.0M | $320.6M | $329.6M |
| Income tax | $177.7M | $163.2M | $29.0M | $111.8M | $113.7M | $92.2M | $94.5M | $80.8M | $59.7M | $62.1M |
| Net income | $552.5M | $513.7M | $631.3M | $353.4M | $369.4M | $308.3M | $304.9M | $282.0M | $263.1M | $269.7M |
| EPS, basic | 3.18 | 2.88 | 3.46 | 1.92 | 1.97 | 1.62 | 1.60 | 1.48 | 1.36 | 1.30 |
| EPS, diluted | 3.13 | 2.85 | 3.41 | 1.88 | 1.91 | 1.57 | 1.56 | 1.45 | 1.34 | 1.28 |
| Shares, diluted (wtd. avg.) | 176.6M | 180.4M | 185.1M | 188.1M | 193.0M | 195.8M | 195.2M | 194.0M | 197.0M | 210.1M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $853.8M | $648.2M | $583.7M | $646.8M | $899.5M | $680.4M | $467.1M | $368.4M | $504.5M | $422.6M |
| Short-term investments | $350.0M | $23.4M | $0 | — | — | — | — | — | — | — |
| Receivables | $1.24B | $1.20B | $1.12B | $994.8M | $887.7M | $881.0M | $914.3M | $774.2M | $693.1M | $615.3M |
| Total current assets | $2.66B | $2.08B | $1.89B | $1.78B | $1.92B | $1.75B | $1.55B | $1.36B | $1.43B | $1.23B |
| Property, plant and equipment | $190.4M | $207.9M | $189.8M | $180.8M | $215.1M | $231.1M | $254.0M | $212.7M | $207.0M | $193.2M |
| Goodwill | $1.78B | $1.67B | $1.68B | $1.68B | $1.73B | $1.70B | $1.57B | $1.39B | $1.34B | $1.07B |
| Other intangibles | $67.0M | $26.9M | $53.0M | $89.7M | $169.6M | $236.7M | $230.9M | $177.1M | $131.6M | $78.9M |
| Total assets | $5.84B | $4.99B | $4.81B | $4.59B | $4.98B | $4.87B | $4.45B | $3.53B | $3.45B | $2.89B |
| Accounts payable | $27.5M | $36.5M | $27.7M | $35.8M | $25.0M | $13.9M | $22.0M | $42.6M | $15.1M | $9.8M |
| Short-term debt | $376.0M | $26.2M | $432.2M | $26.1M | $383.4M | $33.5M | $33.5M | $33.5M | $39.2M | $39.2M |
| Total current liabilities | $1.60B | $963.7M | $1.32B | $1.10B | $1.31B | $1.20B | $910.2M | $976.3M | $838.8M | $731.4M |
| Long-term debt | $1.17B | $1.20B | $824.7M | $1.25B | $1.27B | $1.31B | $1.34B | $975.6M | $1.01B | $698.2M |
| Total liabilities | $3.29B | $2.60B | $2.56B | $2.76B | $3.08B | $3.04B | $2.77B | $2.13B | $2.02B | $1.59B |
| Retained earnings | $1.39B | $1.24B | $1.09B | $780.0M | $732.5M | $741.7M | $648.7M | $438.5M | $356.0M | $358.1M |
| Total equity | $2.55B | $2.39B | $2.25B | $1.83B | $1.90B | $1.83B | $1.69B | $1.40B | $1.42B | $1.29B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $812.9M | $615.4M | $490.8M | $443.7M | $694.3M | $584.3M | $427.9M | $339.5M | $359.1M | $345.8M |
| Depreciation and amortisation | $70.7M | $69.8M | $72.5M | $86.8M | $109.1M | $116.5M | $96.1M | $64.9M | $58.5M | $54.6M |
| Stock-based compensation | $89.6M | $66.4M | $88.6M | $77.4M | $82.0M | $74.0M | $83.9M | $49.0M | $35.7M | $25.1M |
| Capital expenditure | $78.2M | $82.8M | $55.4M | $50.6M | $53.3M | $70.2M | $74.9M | $85.0M | $57.2M | $81.9M |
| Investing cash flow | -$495.5M | -$106.0M | -$78.9M | -$36.6M | -$122.7M | -$266.4M | -$357.1M | -$276.1M | -$362.0M | -$125.8M |
| Financing cash flow | -$106.8M | -$424.8M | -$483.0M | -$571.4M | -$332.9M | -$92.0M | $39.6M | -$135.2M | $47.2M | -$232.8M |
| Dividends paid | $117.7M | $108.5M | $100.0M | $91.8M | $80.5M | $74.2M | $64.7M | $57.1M | $46.7M | — |
| Buybacks | — | $252.7M | $225.5M | $214.1M | $298.2M | $137.1M | $30.0M | $154.2M | $219.8M | $345.2M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001398659-26-000004.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.57B | $2.74B | $3.00B | $3.52B | $3.71B | $4.02B | $4.37B | $4.48B | $4.77B | $5.08B |
| Gross profit | $1.02B | $1.06B | $1.08B | $1.23B | $1.29B | $1.43B | $1.54B | $1.57B | $1.69B | $1.83B |
| Net income | $269.7M | $263.1M | $282.0M | $304.9M | $308.3M | $369.4M | $353.4M | $631.3M | $513.7M | $552.5M |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Results announced Item 2.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Results announced Item 2.02
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
- Results announced Item 2.02
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Officer or director change Item 5.02
- Results announced Item 2.02
- Officer or director change Item 5.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 8742
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| BAH | Booz Allen Hamilton Holding Corp | $9.42B | 11.4x | -6.4% |
| FCN | FTI CONSULTING, INC | $4.34B | 19.1x | 2.4% |
| EXPO | EXPONENT INC | $3.68B | 37.4x | 4.2% |
| HURN | Huron Consulting Group Inc. | $3.17B | 33.5x | 11.9% |
| ASTH | Astrana Health, Inc. | $2.09B | 81.4x | 56.4% |
| ICFI | ICF International, Inc. | $1.69B | 19.1x | -7.3% |
| BWMN | Bowman Consulting Group Ltd. | $742.5M | 58.7x | 14.9% |
| ONT | Onterris, Inc. | $520.8M | — | 19.3% |